Drug-Coated Balloon Angioplasty in Atherosclerosis Patients With Popliteal Artery Involvement
Published on 2018-07-10T12:00:00Z (GMT) by
<div><p><b>Purpose:</b> To investigate outcomes of drug-coated balloon (DCB) angioplasty in endovascular interventions including or restricted to the popliteal artery. <b>Methods:</b> A retrospective analysis was conducted of 266 patients [median age 72 years, interquartile range (IQR) 62, 78; 166 men] treated with DCB angioplasty in 281 de novo lesions including the popliteal artery between December 2011 and January 2015 at a single center. The median lesion length was 270 mm (IQR 150, 373). The study outcomes were primary patency and predictors of restenosis [reported as the hazard ratio (HR) with 95% confidence interval (CI)]. <b>Results:</b> The primary patency was 77.4% at a median 12.2 months (IQR 5.7, 18.8). Independent variables associated with restenosis included baseline Rutherford category (HR 1.36, 95% CI 1.05 to 1.77, p=0.02), reference vessel diameter (HR 0.77, 95% CI 0.63 to 0.95, p=0.02), dissection (HR 1.69, 95% CI 1.022.79, p=0.04), and standard nitinol stent use (HR 2.08, 95% CI 1.14 to 3.79, p=0.02). <b>Conclusion:</b> Outcomes after DCB angioplasty in lesions including the popliteal artery were acceptable compared with previous studies. Further investigation with long-term follow-up is needed to confirm these results.</p></div>
Cite this collection
Dohi, Tomoharu; Schmidt, Andrej; Scheinert, Dierk; Bausback, Yvonne; Kabata, Daijiro; Shintani, Ayumi; et al. (2018): Drug-Coated Balloon Angioplasty in Atherosclerosis Patients With Popliteal Artery Involvement. SAGE Journals. Collection.